vaccines Tag

Bioinnovo scientist will lecture on innovation in babesiosis vaccines at Afrivet 2022

Bioinnovo, comprised of Vetanco and IncuINTA (INTA‘s technical-organizational platform for the development of technological projects) is the first public-private Technology-Based biotechnology Company (TBC) and will be present at the Afrivet Technical Conference 2022 to be held on August 2 and 4 at the Protea Hotel Fire & Ice in Menlyn,…

BVDV Differential Diagnosis and Management Strategies

The Workshop “BVDV Differential Diagnosis and Management Strategies” took place as part of the first International Congress on BVDV. Bioinnovo, the first public-private company created by Vetanco and the National Institute of Agricultural Technology (INTA), aimed at investigating, designing and developing IgY antibodies and recombinant vaccines, and at…

Second day of the International Congress on BVDV

The second day of the First International Congress on Bovine Viral Diarrhea Virus (BVDV) was held last Monday, August 2, and dealt with the different available vaccines and vaccination strategies to fight against this virus, responsible for millions of dollars in losses to national farms….

Bioinnovo, recognized in the 6th edition of the Israel Innovation Awards

The virtual awards ceremony of the 6th edition of the “Israel Innovation Awards” took place on July 14th. The event was organized by the Ministry of Science, Technology and Innovation of the Argentine Republic, the Israeli Embassy in Argentina  and the Argentine-Israel Chamber of Commerce. The event featured the participation of…